You are leaving Evergreentgn.com
You have clicked on an external link and will be taken offsite.
Cancel
Confirm
Lantheus has completed its acquisition of Evergreen Theragnostics, Inc. Please see the
press release
to learn more.
CDMO
Pipeline
Therapeutic Areas
Menu
About us
Facilities
News
Careers
CDMO
Products & Pipeline
Therapeutic Areas
About us
Facilities
News
Careers
menu
Close
CDMO
Products & Pipeline
Therapeutic Areas
Menu
About us
Facilities
News
Careers
CDMO
Products & Pipeline
Therapeutic Areas
About us
Facilities
News
Careers
menu
Improving the options for cancer patients through theragnostic radiopharmaceuticals
